Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Disease Management : DM|April 9, 2005
Economic effectiveness of disease management programs: a meta-analysisDavid S KrausePharmacogenomics|March 17, 2022
Use of a consultation service following pharmacogenetic testing in psychiatryDavid S Krause, Daniel DowdDepression and Anxiety|May 9, 2020
Randomized, controlled, participant- and rater-blind trial of pharmacogenomic test-guided treatment versus treatment as usual for major depressive disorderRoy H Perlis, Daniel Dowd, Maurizio Fava, et al.The American Journal of Managed Care|November 14, 2022
Predicting drug-drug and drug-gene interactions in a community pharmacy populationDaniel Dowd, Gabriela Williams, Daniel VanDorn, et al.Antimicrobial Agents and Chemotherapy|May 25, 2004
Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemiaDavid S Krause, John Reinhardt, Jose A Vazquez, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasisDavid S Krause, A E Simjee, Christo van Rensburg, et al.The Journal of Pediatrics|March 6, 2004
Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infantsG William Letson, Craig N Shapiro, Deborah Kuehn, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 23, 2012
A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trialNeil Binkley, Michael Bolognese, Anna Sidorowicz-Bialynicka, et al.The New England Journal of Medicine|June 15, 2007
Anidulafungin versus fluconazole for invasive candidiasisAnnette C Reboli, Coleman Rotstein, Peter G Pappas, et al.Pageof 1